{"id":"https://openalex.org/W2563645105","doi":"https://doi.org/10.1182/blood.v126.23.3703.3703","title":"The ATM Inhibitor KU60019 Synergizes the Antineoplastic Effect of Romidepsin in Mantle Cell Lymphoma (MCL)","display_name":"The ATM Inhibitor KU60019 Synergizes the Antineoplastic Effect of Romidepsin in Mantle Cell Lymphoma (MCL)","publication_year":2015,"publication_date":"2015-12-03","ids":{"openalex":"https://openalex.org/W2563645105","doi":"https://doi.org/10.1182/blood.v126.23.3703.3703","mag":"2563645105"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v126.23.3703.3703","doi":"https://doi.org/10.1182/blood.v126.23.3703.3703","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.3703.3703","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016848239","display_name":"Luigi Scotto","orcid":"https://orcid.org/0000-0002-7071-926X","observed_orcids":["https://orcid.org/0000-0002-7071-926X"]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Luigi Scotto","raw_affiliation_strings":["Center for Lymphoid Malignancies, Department of Medicine, Columbia University Medical Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Lymphoid Malignancies, Department of Medicine, Columbia University Medical Center, New York, NY","institution_ids":["https://openalex.org/I2799503643"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025001761","display_name":"Xavier Jirau-Serrano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xavier Jirau-Serrano","raw_affiliation_strings":["Center for Lymphoid Malignancies, Department of Medicine, Columbia University Medical Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Lymphoid Malignancies, Department of Medicine, Columbia University Medical Center, New York, NY","institution_ids":["https://openalex.org/I2799503643"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058238903","display_name":"Kelly M. Zullo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kelly Zullo","raw_affiliation_strings":["Center for Lymphoid Malignancies, Department of Medicine, Columbia University Medical Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Lymphoid Malignancies, Department of Medicine, Columbia University Medical Center, New York, NY","institution_ids":["https://openalex.org/I2799503643"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016606718","display_name":"Michael A. Mangone","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Mangone","raw_affiliation_strings":["Center for Lymphoid Malignancies, Department of Medicine, Columbia University Medical Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Lymphoid Malignancies, Department of Medicine, Columbia University Medical Center, New York, NY","institution_ids":["https://openalex.org/I2799503643"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075692970","display_name":"Jennifer Effie Amengual","orcid":"https://orcid.org/0000-0003-4117-2469","observed_orcids":["https://orcid.org/0000-0003-4117-2469"]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer E Amengual","raw_affiliation_strings":["Center for Lymphoid Malignancies, Department of Medicine, Columbia University Medical Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Lymphoid Malignancies, Department of Medicine, Columbia University Medical Center, New York, NY","institution_ids":["https://openalex.org/I2799503643"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101491956","display_name":"Changchun Deng","orcid":"https://orcid.org/0000-0001-9372-6086","observed_orcids":["https://orcid.org/0000-0001-9372-6086"]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Changchun Deng","raw_affiliation_strings":["Center for Lymphoid Malignancies, Columbia University Medical Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Lymphoid Malignancies, Columbia University Medical Center, New York, NY","institution_ids":["https://openalex.org/I2799503643"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5002126535","display_name":"Owen A. O\u2019Connor","orcid":"https://orcid.org/0000-0002-5631-0011","observed_orcids":["https://orcid.org/0000-0002-5631-0011"]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Owen A. O'Connor","raw_affiliation_strings":["Center for Lymphoid Malignancies, Department of Medicine, Columbia University Medical Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Lymphoid Malignancies, Department of Medicine, Columbia University Medical Center, New York, NY","institution_ids":["https://openalex.org/I2799503643"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I2799503643"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.19600004,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"126","issue":"23","first_page":"3703","last_page":"3703"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.8202999830245972,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.8202999830245972,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.14329999685287476,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.006099999882280827,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atm-inhibitors","display_name":"ATM inhibitors","score":0.8420000076293945},{"id":"https://openalex.org/keywords/mantle-cell-lymphoma","display_name":"mantle cell lymphoma","score":0.9660000205039978},{"id":"https://openalex.org/keywords/histone-deacetylase-inhibitors","display_name":"histone deacetylase inhibitors","score":0.7710000276565552},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6510000228881836},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.7160000205039978},{"id":"https://openalex.org/keywords/p21","display_name":"p21","score":0.9950000047683716},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.8190000057220459},{"id":"https://openalex.org/keywords/caspase-activation","display_name":"caspase activation","score":0.7990000247955322},{"id":"https://openalex.org/keywords/bcl-xl","display_name":"Bcl-xL","score":0.8029999732971191},{"id":"https://openalex.org/keywords/bcl-2","display_name":"Bcl-2","score":0.9259999990463257},{"id":"https://openalex.org/keywords/dna-damage-response","display_name":"DNA damage response","score":0.6140000224113464},{"id":"https://openalex.org/keywords/gamma-h2ax","display_name":"\u03b3H2AX","score":0.7950000166893005},{"id":"https://openalex.org/keywords/parp1-cleavage","display_name":"PARP-1 cleavage","score":0.8450000286102295},{"id":"https://openalex.org/keywords/cell-cycle-arrest","display_name":"cell cycle arrest","score":0.7310000061988831},{"id":"https://openalex.org/keywords/xenografts","display_name":"xenografts","score":0.6769999861717224}],"concepts":[{"id":"https://openalex.org/C2781462825","wikidata":"https://www.wikidata.org/wiki/Q7363205","display_name":"Romidepsin","level":5,"score":0.8754518032073975},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.5970991253852844},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.581475555896759},{"id":"https://openalex.org/C2777525834","wikidata":"https://www.wikidata.org/wiki/Q268713","display_name":"Mantle cell lymphoma","level":3,"score":0.5330312252044678},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.5137742161750793},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.4985644817352295},{"id":"https://openalex.org/C53227056","wikidata":"https://www.wikidata.org/wiki/Q189152","display_name":"Viability assay","level":3,"score":0.4912082552909851},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.4629002809524536},{"id":"https://openalex.org/C2776415932","wikidata":"https://www.wikidata.org/wiki/Q48743","display_name":"Western blot","level":3,"score":0.4473131597042084},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4359484314918518},{"id":"https://openalex.org/C191560914","wikidata":"https://www.wikidata.org/wiki/Q7390592","display_name":"SKBR3","level":5,"score":0.42216262221336365},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.413602739572525},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.41291964054107666},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.38150283694267273},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.33629488945007324},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.2903367280960083},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.14920854568481445},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.14248597621917725},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.12856867909431458},{"id":"https://openalex.org/C2778305200","wikidata":"https://www.wikidata.org/wiki/Q174378","display_name":"Histone deacetylase","level":4,"score":0.08588585257530212},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C64927066","wikidata":"https://www.wikidata.org/wiki/Q36293","display_name":"Histone","level":3,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C2994423619","wikidata":"https://www.wikidata.org/wiki/Q9103","display_name":"Human breast","level":4,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v126.23.3703.3703","doi":"https://doi.org/10.1182/blood.v126.23.3703.3703","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.3703.3703","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2487709308","https://openalex.org/W3088612562","https://openalex.org/W2322485419","https://openalex.org/W2152694994","https://openalex.org/W2559998322","https://openalex.org/W2989946485","https://openalex.org/W918949378","https://openalex.org/W2740723543","https://openalex.org/W2514135529","https://openalex.org/W7099213255"],"abstract_inverted_index":{"Abstract":[0],"Introduction:":[1],"Romidepsin":[2,328],"(R),":[3],"an":[4,93,277,533,619],"HDAC":[5,53,583],"inhibitor":[6,38,95,401],"(HDACi)":[7],"approved":[8],"for":[9,356],"the":[10,27,33,36,75,88,99,147,186,193,218,252,267,288,294,297,322,325,341,361,368,374,378,383,389,392,396,399,404,421,430,433,479,494,503,511,539,549,566,576],"treatment":[11,308,370,385],"of":[12,29,35,42,92,146,195,202,237,251,266,280,287,296,314,324,344,353,391,398,413,426,432,445,452,482,487,496,506,510,513,548,582,622],"relapsed":[13],"T-cell":[14],"lymphoma,":[15],"is":[16,32,154,555],"thought":[17],"to":[18,26,48,51,59,73,86,240,388,394,469,498,538],"induce":[19,470,499],"cell":[20,30,111,131,138,183,205,220,244,254,273,357,407,437,524,570],"cycle":[21,132,245,358,408,438],"arrest":[22,359],"and":[23,125,130,141,152,171,211,247,259,285,301,339,409,420,442,464,529,584,591],"apoptosis.":[24,248,345],"Central":[25],"block":[28],"proliferation":[31],"up-regulation":[34,41,397],"cdk":[37,400],"p21Cip1/Waf1.":[39,104],"Interestingly":[40],"p21Cip1/Waf1":[43,61,76,402,434],"has":[44,70],"also":[45,531],"been":[46,71],"shown":[47,72,532],"reduce":[49],"sensitivity":[50],"romidepsin.":[52],"inhibitors":[54],"as":[55,149],"a":[56,66,80,157,214,235,304,559,589],"class":[57],"appear":[58],"activate":[60],"expression":[62,118,230,350,472,480,504],"via":[63,122,136],"ATM.":[64],"KU60019,":[65],"specific":[67],"ATM":[68,94,585],"inhibitor,":[69],"decrease":[74,306],"protein":[77,229,349,410,484],"levels":[78,505],"in":[79,180,217,234,243,270,276,321,360,382,429,457,478,515,519,542,551,558,594],"concentration":[81],"dependent":[82],"manner.":[83],"We":[84],"sought":[85],"explore":[87],"potential":[89,100,545],"synergistic":[90,175,535,590],"interaction":[91],"with":[96,190,208,226,309,318,373,417,517,553],"R,":[97,354],"given":[98],"complementary":[101],"effects":[102],"around":[103],"Methods:":[105],"For":[106],"all":[107,181,196,203,271],"cytotoxicity":[108],"assays,":[109],"luminescent":[110],"viability":[112],"was":[113,120,178,188,224,262,364,371,386],"performed":[114,121,167],"using":[115,156,168,565],"CellTiter-GloTM.":[116],"Gene":[117],"analysis":[119,133,201,231,412,444],"Western":[123,142,440],"blot":[124,441],"semi-quantitative":[126],"PCR":[127],"assay.":[128],"Apoptosis":[129],"were":[134,166],"analyzed":[135],"Fluorescence-activated":[137],"sorting":[139],"(FACS)":[140],"blot.":[143],"The":[144,346,544],"efficacy":[145],"compounds":[148],"single":[150,209,268,326,418],"agent":[151],"combination":[153,212,384,422,516,552],"evaluated":[155,557],"subcutaneous":[158,561],"xenograft":[159,562],"MCL":[160,182,560],"mouse":[161,563],"model.":[162],"Results:":[163],"Synergy":[164],"analyses":[165],"Jeko-1,":[169],"Maver-1":[170],"Z-138":[172,567],"cells.":[173],"A":[174,476,508],"cytotoxic":[176],"effect":[177,512,536,547],"observed":[179,263,366,381,541],"lines":[184,206,525],"when":[185,222,316,367],"HDACi":[187,456,497,550],"combined":[189,225,372],"KU60019":[191,315,375,393,427,465,488,492,518,554],"throughout":[192],"range":[194],"tested":[197],"concentrations.":[198],"Flow":[199],"cytometry":[200],"three":[204,272],"treated":[207,416],"agents":[210,269,419],"indicated":[213,449],"substantial":[215],"increase":[216],"apoptotic":[219],"fraction":[221],"R":[223,310,369,467,514],"KU60019.":[227],"Furthermore":[228],"revealed":[232],"changes":[233],"host":[236],"proteins":[238,256,299],"known":[239],"be":[241,588],"involved":[242],"control":[246],"Increased":[249],"activation":[250,451],"programmed":[253],"death":[255],"Caspase":[257,260],"8":[258],"3":[261],"upon":[264,351,485],"combinations":[265],"lines,":[274],"resulting":[275],"increased":[278,312,347,379],"cleavage":[279],"Poly":[281],"(ADP-ribose)":[282],"polymerase":[283],"(PARP-1)":[284],"accumulation":[286],"DNA":[289],"damage":[290],"marker":[291],"gammaH2AX.":[292],"Finally,":[293],"abundance":[295,320],"anti-apoptotic":[298],"Bcl-XL":[300],"BCL-2":[302],"showed":[303],"significant":[305],"after":[307],"plus":[311],"concentrations":[313],"compared":[317],"their":[319],"presence":[323],"agents.":[327],"kill":[329],"tumor":[330,521],"cells":[331,415,459],"by":[332,403,455,501],"driving":[333],"premature":[334],"exit":[335],"from":[336],"aberrant":[337],"mitosis":[338],"inducing":[340],"rapid":[342],"onset":[343],"p21":[348,446,471],"addition":[352,425,486],"responsible":[355],"G2/M":[362,436],"phase,":[363],"not":[365],"suggesting":[376],"that":[377,424,450,491,579],"apoptosis":[380],"due":[387],"ability":[390,468,495],"affect":[395,493],"HDACi.":[405],"Indeed":[406],"expession":[411],"Jeko-1":[414,458],"confirmed":[423],"results":[428],"inhibition":[431,586],"induced":[435],"arrest.":[439],"transfection":[443],"promoter":[447],"constructs":[448],"p21(WAF1/Cip1)":[453,500],"transcription":[454],"occurs":[460],"through":[461],"Sp1":[462],"sites":[463],"affected":[466],"at":[473],"transcriptional":[474],"level.":[475],"decreased":[477],"level":[481],"SP1":[483],"would":[489],"suggest":[490],"modulating":[502],"SP1.":[507],"survey":[509],"other":[520],"types":[522],"derived":[523,569],"(CTCL,":[526],"DLBCL,":[527],"TALL":[528],"ATLL)":[530],"overall":[534],"similar":[537],"one":[540],"MCL.":[543,595],"therapeutic":[546],"currently":[556],"model":[564],"lymphoma":[568],"line.":[571],"Conclusions:":[572],"These":[573],"data":[574],"support":[575],"novel":[577],"concept":[578],"dual":[580],"targeting":[581],"may":[587],"effective":[592],"strategy":[593],"Disclosures":[596],"Amengual:":[597],"Acetylon":[598],"Pharmaceuticals,":[599],"INC:":[600],"Consultancy,":[601,615,630,636,643,648,655,667,670],"Research":[602,608,612,627,638,660,664,671],"Funding.":[603,613,672],"Deng:TG":[604],"Therapeutics,":[605],"Inc.:":[606],"Honoraria,":[607,616,637,649,656],"Funding;":[609,628,639,661,665],"Seattle":[610,662],"Genetics:":[611,663],"O'Connor:Celgene:":[614],"Membership":[617],"on":[618],"entity's":[620],"Board":[621],"Directors":[623],"or":[624],"advisory":[625],"committees,":[626],"Acetylon:":[629],"Other:":[631,644,650,657],"Consultancy":[632,645,651,658],"fee;":[633,646,652],"Spectrum":[634],"Pharmaceuticals:":[635],"Bristol-Myers":[640],"Squibb":[641],"Company:":[642],"Novartis:":[647],"Takeda":[653],"Millenium:":[654],"fee,":[659],"Bayer:":[666],"Honoraria;":[668],"Mundipharma:":[669]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":1}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2017-01-06T00:00:00"}